Amrize (NYSE:AMRZ) Cut to “Hold” at Berenberg Bank

Berenberg Bank downgraded shares of Amrize (NYSE:AMRZ) from a buy rating to a hold rating in a research note published on Monday, MarketBeat Ratings reports. The brokerage currently has $46.00 target price on the stock, down from their prior target price of $48.00.

Several other brokerages have also recently issued reports on AMRZ. DA Davidson boosted their price objective on shares of Amrize from $40.00 to $43.00 and gave the company a “neutral” rating in a research note on Friday, October 30th. Wells Fargo & Company reduced their target price on shares of Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a research note on Friday, October 30th. William Blair set a $40.00 target price on shares of Amrize in a report on Wednesday, September 2nd. Zacks Research lowered shares of Amrize from a “hold” rating to a “strong sell” rating in a research note on Wednesday, August 19th. Finally, Longbow Research began coverage on shares of Amrize in a report on Monday, October 12th. They set a “buy” rating for the company. Eight research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, Amrize currently has a consensus rating of “Hold” and an average target price of $47.65.

Amrize Stock Down 0.9%

Amrize stock opened at $41.58 on Monday. Amrize has a twelve month low of $35.78 and a twelve month high of $65.94. The stock has a 50 day moving average of $39.43 and a two-hundred day moving average of $50.12. The company has a current ratio of 1.07, a quick ratio of 0.67 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $22.99 billion, a price-to-earnings ratio of 18.81, a PEG ratio of 1.64 and a beta of 0.04.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting the consensus estimate of $1.05. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The business had revenue of $3.77 billion during the quarter. During the same quarter last year, the company earned $0.98 EPS. Amrize’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, research analysts expect that Amrize will post 2.30 earnings per share for the current year.

Amrize Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Investors of record on Tuesday, November 10th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio is currently 4.98%.

Insiders Place Their Bets

In other Amrize news, CEO Jan Jenisch acquired 26,000 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was purchased at an average price of $42.47 per share, for a total transaction of $1,104,220.00. Following the completion of the transaction, the chief executive officer owned 1,767,000 shares of the company’s stock, valued at $75,044,490. The trade was a 1.49% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jacques Sanche bought 4,150 shares of Amrize stock in a transaction on Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the acquisition, the director owned 9,766 shares of the company’s stock, valued at $439,665.32. This trade represents a 73.90% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 34,155 shares of company stock worth $1,461,276 in the last ninety days. 0.54% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Amrize

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC lifted its stake in shares of Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock valued at $263,371,000 after purchasing an additional 171,622 shares during the period. Pictet Asset Management Holding SA grew its position in Amrize by 4.3% during the third quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company’s stock worth $230,110,000 after buying an additional 253,512 shares during the period. Renaissance Technologies LLC increased its holdings in Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after buying an additional 183,900 shares in the last quarter. Amundi increased its holdings in Amrize by 30.9% in the first quarter. Amundi now owns 1,654,739 shares of the company’s stock valued at $92,698,000 after buying an additional 390,750 shares in the last quarter. Finally, Swiss National Bank increased its holdings in Amrize by 7.1% in the first quarter. Swiss National Bank now owns 1,460,874 shares of the company’s stock valued at $81,838,000 after buying an additional 96,800 shares in the last quarter.

About Amrize

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.